Royalty Pharma 

Royalty Pharma 

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$674,141
$630,576
$621,990
$609,291
Gross Profit
405,925
629,405
621,990
609,291
EBITDA
176,397
563,149
451,280
525,052
EBIT
175,103
561,978
450,084
523,775
Net Income
17,883
295,000
214,205
288,217
Net Change In Cash
674,141
630,576
621,990
609,291
Free Cash Flow
686,155
760,539
827,148
702,615
Cash
812,000
586,395
619,000
938,944
Basic Shares
556,896
559,611
559,611
559,611

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,378,193
$2,263,576
$2,354,554
$2,237,215
Gross Profit
2,378,193
2,263,576
2,354,554
2,237,215
EBITDA
1,635,708
1,556,325
1,887,275
423,695
EBIT
1,631,856
1,292,444
1,492,150
418,025
Net Income
770,947
858,983
1,134,834
42,832
Net Change In Cash
2,378,193
2,263,576
2,354,554
2,237,215
Cost of Revenue
169,703
Free Cash Flow
2,489,823
2,768,986
2,987,802
4,185,132
Cash
618,696
929,026
477,010
1,710,751
Basic Shares
559,611
594,000
602,900
564,931

Earnings Calls

QuarterEPS
2026-06-30
$1.32
2026-03-31
$1.30
2025-12-31
$1.47
2025-09-30
$1.17